Ustekinumab-Induced Remission of Two Cases of Refractory Cutaneous Crohn's Disease

被引：2
|
作者：
Patel, Bansri M. [1 ]
Ramos Rivers, Claudia [2 ]
Koutroumpakis, Filippos [2 ]
Ahsan, Maaz [1 ]
Dueker, Jeffrey [2 ]
Hashash, Jana [2 ]
Johnston, Elyse [2 ]
Barrie, Arthur [2 ]
Harrison, Janet [2 ]
Schwartz, Marc [2 ]
Babichenko, Dmitriy [2 ]
Tang, Gong [2 ]
Binion, David [2 ]
机构：
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[2] Univ Pittsburgh, Med Ctr, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA
来源：
INFLAMMATORY BOWEL DISEASES | 2021年 / 27卷 / 10期
关键词：
cutaneous Crohn's disease; ustekinumab; biologic therapy; anti-TNF therapy; dermatologic manifestation;
D O I：
10.1093/ibd/izab115
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E124 / E124
页数：1
相关论文
共 50 条
  • [1] Treatment of refractory cutaneous Crohn's disease with ustekinumab
    Patel, B. M.
    Rivers, C. Ramos
    Koutroumpakis, F.
    Ahsan, M.
    Dueker, J.
    Hashash, J.
    Johnston, E.
    Barrie, A.
    Harrison, J.
    Schwartz, M.
    Babichenko, D.
    Tang, G.
    Binion, D. G.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S72 - S72
  • [2] Ustekinumab-induced leukocytoclastic vasculitis in a young male with Crohn's disease
    Zhang, Xiao-Peng
    Wang, Huan
    Zhu, Liang-ru
    [J]. DIGESTIVE AND LIVER DISEASE, 2024, 56 (06) : 1105 - 1106
  • [3] Ustekinumab-induced subacute cutaneous lupus: first reported case
    Tierney, E.
    Kirthi, S.
    Ramsay, B.
    Ahmad, K.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 : 74 - 74
  • [4] Intensification with intravenous ustekinumab in refractory Crohn′s disease
    Arroyo Arguelles, J. M.
    Suarez Ferrer, C.
    Rueda Garcia, J. L.
    Martin-Arranz, E.
    Poza Cordon, J.
    Sanchez-Azofra, M.
    Garcia-Ramirez, L.
    Martin-Arranz, M. D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : 866 - 868
  • [5] Intensification with Intravenous Ustekinumab in Refractory Crohn's Disease
    Ferrer, Cristina Suarez
    Arguelles, Jose Arroyo
    Garcia, Jose Luis Rueda
    Ramirez, Laura Garcia
    Arranz, Eduardo Martin
    Azofra, Maria Sanchez
    Cordon, Joaquin Poza
    Belda, Jesus Noci
    Martin-Arranz, Maria Dolores
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)
  • [6] Ustekinumab and remission in perianal Crohn's disease: A case report
    Alcantara-Figueroaa, C. E.
    Coronado-Rivera, E. F.
    Estela-Vasquezb, E. F.
    Calderon-Cabreraa, D. C.
    Alcantara-Ascon, R. A.
    [J]. REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2023, 88 (04): : 431 - 432
  • [7] CROHN'S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE IL23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS
    Onali, S.
    Di, Petrillo A.
    Favale, A.
    Carpineti, C.
    Cadoni, M.
    Loddo, E.
    Fantini, M. C.
    [J]. DIGESTIVE AND LIVER DISEASE, 2023, 55 : S159 - S159
  • [8] Cutaneous Vasculitis After Ustekinumab Induction in Crohn's Disease
    Chugh, Rishika
    Proctor, Deborah D.
    Little, Alicia
    Myung, Peggy
    Cowper, Shawn
    Imaeda, Suguru
    Pashankar, Dinesh S.
    Al-Bawardy, Badr
    [J]. INFLAMMATORY BOWEL DISEASES, 2021, 27 (03) : E30 - E31
  • [9] Ustekinumab in the Successful Treatment of Refractory Esophageal Crohn's Disease
    Barkin, Jodie A.
    Deshpande, Amar R.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S288 - S288
  • [10] Ustekinumab in super-refractory Crohn's disease patients
    Herrera, C.
    Robles, V.
    Jimenez, C.
    Navarro, E.
    Casellas, F.
    Borruel, N.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S262 - S263
12345